Deal snapshot: Azurity Pharmaceuticals Acquires Slayback Pharma from KKR and Everstone Capital.

MANews-(C)2009-2023

US-based pharmaceutical company Azurity Pharmaceuticals, Inc. has acquired New Jersey based pharmaceutical company Slayback Pharma LLC from existing investors, including investment firm KKR and Everstone Capital, the company said.

Terms of the transaction were...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT